MedPath

MYCAMINE

MYCAMINE

Approved
DIN Number

02311054

Drug Class

Human

Market Date

Dec 17, 2009

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02311054
AIG Number0152203003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J02AX05 MICAFUNGIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:14.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

MICAFUNGIN SODIUMActive
Strength: 100 MG / VIAL
Monograph: MICAFUNGIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.